Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
French National Agency for Research on AIDS and Viral Hepatitis |
---|---|
Information provided by: | French National Agency for Research on AIDS and Viral Hepatitis |
ClinicalTrials.gov Identifier: | NCT00623051 |
This study is aimed at demonstrating whether or not Male Circumcision can be used as an effective public health prevention tool that will have an impact on HIV prevalence in the South African population.
Condition | Intervention |
---|---|
HIV Infections |
Procedure: Male Circumcision |
Study Type: | Interventional |
Study Design: | Prevention, Open Label, Single Group Assignment |
Official Title: | Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2) |
Estimated Enrollment: | 27300 |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | July 2012 |
Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Male circumcision by experimented doctor or nurse
|
Procedure: Male Circumcision |
A randomized, controlled trial (ANRS 1265) conducted in Orange Farm (South Africa) has demonstrated that male circumcision (MC) can reduce the risk of HIV acquisition by more than 50% among young men. This result has been confirmed by two similar studies conducted in Uganda and in Kenya.
Giving these findings, the next logical step is to demonstrate whether or not MC can be used as an effective public health prevention tool that will have an impact on HIV in populations as well as among individuals.
This research study aims to establish a MC intervention in the community where the first randomized controlled trial of the impact of MC on men's risk of acquiring HIV infection was carried out in order to evaluate its impact on:
This research will be carried out over a period of 60 months and will have three major components: (1) the delivery of the intervention, (2) quantitative studies (cross-sectional surveys), and (3) qualitative studies.
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Dirk Taljaard | 27 11 782 56 87 | dirk@progressus.co.za |
South Africa, Johannesburg | |
Male Circumcision Centre | Recruiting |
Orange Farm, Johannesburg, South Africa | |
Contact: Dirk Taljaard 27 11 782 56 87 dirk@progressus.co.za |
Principal Investigator: | Bertran Auvert, MD, PhD | University of Versailles, INSERM U687, France |
Principal Investigator: | David Lewis, MD | NICD, Johannesburg |
Principal Investigator: | Mohamed Haffejee, MD | Wits Medical School, Urology Department, Johannesburg |
Responsible Party: | ANRS ( Director ) |
Study ID Numbers: | ANRS 12126 ORANGE FARM 2 |
Study First Received: | February 11, 2008 |
Last Updated: | April 29, 2009 |
ClinicalTrials.gov Identifier: | NCT00623051 History of Changes |
Health Authority: | South Africa: Department of Health, Gauteng |
male circumcision HIV sexual behavior HIV prevention HIV Seronegativity |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Orange Retroviridae Infections Immunologic Deficiency Syndromes |
Virus Diseases Sexually Transmitted Diseases, Viral RNA Virus Infections Slow Virus Diseases Immune System Diseases HIV Infections |
Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Lentivirus Infections Infection Retroviridae Infections Immunologic Deficiency Syndromes |